Haleon Stock Price, News & Analysis

Glasgow Caledonian University (HLN) will lead a £2.6m, six-year UK doctoral training programme to advance research in oral health and dental disease prevention.

The initiative will support 20 PhD students across five universities, focusing on dental caries prevention, dentine hypersensitivity and gum health, and is funded by BBSRC in partnership with industry partner Haleon. The award is part of a wider £40m package of Industrial Doctoral Landscape Awards and Doctoral Focal Awards announced by UKRI/BBSRC on 16 December 2025.

Haleon (HLN) was honored on December 12, 2025 as a 2025 Fast Company Brands That Matter honoree in the Family of Brands category. The recognition highlights Haleon’s portfolio-level impact, citing cultural relevance, meaningful consumer connection, and purpose-driven innovation across brands such as Sensodyne, Centrum, Advil, Voltaren, Emergen-C, and Theraflu. The company emphasized science-backed products, transparent communication, cross-brand collaboration, and consumer education as drivers of trust and emotional resonance. The award underscores Haleon’s stated mission to expand everyday health access by uniting diverse brands under a shared purpose.

Altibbi partnered with Haleon (HLN) on the Healthy Saudi Smile campaign, announced Nov 24, 2025, to turn oral-health awareness into actionable care across Saudi Arabia.

Altibbi provided Arabic-language, science-based education and connected users to certified doctors for instant consultations, supporting strong engagement and enabling thousands to receive trusted oral-health guidance. The campaign links brand purpose, local expertise, and digital access and aligns with preventive-health priorities in Saudi Vision 2030.

Altibbi plans to expand similar collaborations with health and wellness brands to combine education, access, and care.

Haleon (LSE/NYSE:HLN) announced on October 8, 2025 it selected Salesforce Life Sciences Cloud for Customer Engagement, Data Cloud, and Agentforce to support its global sales organisation. The AI-powered rollout will cover Haleon's 4,500-strong sales force to improve engagement with pharmacies and healthcare professionals and to deliver data-driven insights on consumer demographics, shopping trends, and point-of-sale marketing.

Haleon will serve as a design partner to influence product availability, shelf-life management, promotions, and inventory features for consumer health use cases. The company said the change aims to reduce administrative time for reps and enable more bespoke activation plans for customers worldwide.

Aptar Pharma (NYSE:ATR) has announced a significant sustainability milestone with its Freepod® nasal spray pump, used in Haleon's Otrivin® brand, now being manufactured with 52% bio-based feedstock. This marks the first Aptar delivery system using such materials to be commercialized globally.

The innovative solution features an ISCC Plus certified manufacturing process, with the bottle produced using a mass balance approach equivalent to 100% bio-based content. Combined, the pump and bottle components achieve 60% circular material content for the complete nasal spray device. The manufacturing site in Mezzovico, Switzerland, maintains ISCC PLUS certification, ensuring complete material traceability.

This development supports Haleon's sustainability goals of reducing virgin petroleum-based plastic use by 10% by 2025 and by a third by 2030, compared to 2022 levels.

Haleon (NYSE:HLN) has initiated construction of its new £130 million Global Oral Health Innovation Centre in Weybridge, Surrey. The groundbreaking ceremony was attended by UK Minister Baroness Jones and marks a significant step in Haleon's mission to reach one billion more consumers by 2030.

The state-of-the-art facility will serve as the R&D epicenter for Haleon's oral health portfolio, featuring a digital immersive room for real-time collaboration with its Levice manufacturing site. The center has achieved a BREEAM® Outstanding rating for its sustainability design and will focus on developing solutions for unmet oral health needs globally.

Haleon (NYSE: HLN) has appointed Carl Haney as Chief Research & Development Officer, effective August 1, 2025. Haney joins from Estée Lauder Companies Inc., where he served as Executive Vice President of Global Innovation and R&D for 13 years, following a 20-year tenure at P&G.

Haney succeeds Franck Riot, who is departing after six years with the company. CEO Brian McNamara highlighted Haney's expertise in driving transformative innovation within global consumer businesses, emphasizing his role in implementing Haleon's new Win as One strategy.

TUMS has partnered with DraftKings to launch TUMS Fantasy Foodball Pool, a free online game where players can draft food and drink combinations for a chance to win from a $40,000 prize pool. The initiative comes as a survey reveals that 25% of viewers prioritize food during the big game, with 54% believing gameday food can make or break the experience.

The game features four rounds from January 6 to February 9, each focusing on different themes: Tailgate Foods, Spicy Foods, Sweet Foods, and New Orleans Foods. Players can select from 36 items, including popular gameday foods like barbecue (34%), hot wings (33%), and seven-layer dip (24%). Former football champion Vince Wilfork has joined as a partner to promote the initiative.

TUMS will also host a public event at Bourbon Heat in New Orleans on February 7, offering product samples and exclusive merchandise. The survey, conducted by Talker Research, included 2,000 Americans aged 21-43.